US Stock MarketDetailed Quotes

OVID Ovid Therapeutics

Watchlist
  • 1.050
  • -0.010-0.94%
Close Nov 22 16:00 ET
  • 1.040
  • -0.010-0.95%
Post 20:01 ET
74.56MMarket Cap-2282P/E (TTM)

Ovid Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Ovid Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 100.000K--
--2024/Q4-- / 187.500K--
--2024/Q3173.000K / 70.000K--
--2024/Q2169.000K / 52.880K--
--2024/Q1148.000K / 52.120K--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 100.000K--
--2024/Q4-- / 187.500K--
--2024/Q3173.000K / 70.000K--
--2024/Q2169.000K / 52.880K--
--2024/Q1148.000K / 52.120K--

Unlock Free Earnings Estimates

Ovid Therapeutics Earnings Reports

  • Ovid Therapeutics | 10-Q: Q3 2024 Earnings Report

    Nov 12 22:41

  • Ovid Therapeutics | 8-K: Ovid Therapeutics Reports Business Updates and Third Quarter 2024 Financial Results

    Nov 12 22:40

  • Ovid Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 13 20:07

  • Ovid Therapeutics | 8-K: Ovid Therapeutics Reports Business Updates and Second Quarter 2024 Financial Results

    Aug 13 20:07

    • Read more

    Analysis

    Analyst Rating

    Updated: Nov 14, 2024

    Strong Buy

    • Buy

      83.33%

    • Hold

      16.67%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Latest Price
    % Chg

    No Data